Why is SNDX Down Today?
About Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged...
Overall Confidence: 65%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -2.4%
Market Comparison
🔔 Get SNDX Alerts
We'll notify you when SNDX's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
SNDX has moved more than 3.0% down on 37 occasions in the past year.
Frequently Asked Questions
Why is SNDX stock down today?
This appears to be a sector-wide move. The PHARMACEUTICAL PREPARATIONS sector is down 2.4% on average.
Is SNDX stock a buy or sell right now?
Based on current analysis, SNDX shows 65% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the SNDX stock price target?
SNDX is currently trading at $18.07. Based on today's momentum, the expected short-term range is $17.53 - $18.43. See long-term price prediction →
Will SNDX stock continue falling?
Our analysis shows a 45% probability that SNDX's move continues in the next 1-3 days. Key level to watch: $17.17 (support).
Is SNDX stock oversold or overbought?
SNDX's RSI (Relative Strength Index) is currently at 45.5. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.
What is the momentum for SNDX stock?
SNDX's 10-day momentum indicator is at 0.54. Positive momentum - the stock has mild upward pressure supporting the current trend.
Is SNDX outperforming or underperforming the market?
SNDX (-3.88%) is currently significantly underperforming the market (-4.1% vs SPY). Today, the S&P 500 (SPY) is up 0.18%, and Nasdaq (QQQ) is up 0.31%.
What does MACD indicate for SNDX?
SNDX's MACD (-0.44) is currently above the signal line (-0.54), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 28.2) is strong.
Is SNDX in an uptrend or downtrend?
Based on moving average analysis, SNDX is in a bearish trend. The price ($18.07) is trading below both the 20-day SMA ($18.51) and 50-day SMA ($19.34). This alignment typically indicates sustained downward pressure.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis